to damage to the palpebral branch of the facial nerve. [8] [9] [10] Non-neurological, non-specific clinical signs may include head shaking, pruritus, pain and altered ear carriage. 7 Hearing deficits have also been reported in cats, owing to fluid in the TB or damage to the ossicles of the middle ear. 5, 11 There are several methods for diagnosing OM in cats. Because of their relatively short external ear canal, visualising the TM using otoscopy is relatively easy. Radiography, CT and MRI are commonly used, with CT and MRI being considered more sensitive. 12 Myringotomy can also be useful to collect diagnostic samples from the TB. 13 OM in cats most commonly presents as a result of a nasopharyngeal polyp (NPP) or pharyngeal or upper respiratory infection, which has extended up through the Eustachian tube. Less commonly, OM occurs as an extension of OE and it has also been suggested that a potential cause could be haematogenous spread. 14, 15 OM can either be managed medically or surgically. 16 In cats there is little, if any, information regarding medical management of OM not caused by an NPP. It has been suggested that there is an increased risk of ototoxicity in cats compared with dogs when using topical medications. 5, 17 The aim of this study was to analyse retrospectively cats diagnosed with OM not due to NPP, and look at the clinical outcome with surgical and medical management. The authors hoped to provide some recommendations for treating OM in cats not caused by an NPP.
Materials and methods
A search was performed in the practice management computer record system, using the keywords 'CT bullae' and 'otitis media', for cats. The results were then analysed to check that they fit the criteria; namely, cats of any age that had been referred with or diagnosed at the hospital with OM. Cats with only a presumed diagnosis were excluded, as were those that had CT scans of their bullae for reasons other than OM, such as traumatically avulsed ear canals. Any cat with mention of a middle ear polyp, NPP or 'soft tissue-attenuating material' in the bulla was also excluded.
The diagnosis of OM was based on the presence of clinical signs, including neurological signs, respiratory signs and signs of OE, and on the basis of evidence of thickened or irregular bullae walls, or the presence of fluid within the tympanic cavity, in those that had diagnostic imaging. In those that did not have imaging, the diagnosis was made on the basis of the presence of fluid in the bulla or organisms cultured using myringotomy.
The case files were then analysed and data entered onto an Excel spread sheet. Clinical signs at first presentation were noted, diagnostic techniques employed at the referring practice and the referral hospital, and treatments prescribed. Descriptive statistics were derived from these data using simple percentages. The referring veterinary practice was contacted by telephone to request an up-to-date clinical history for each cat, since its referral.
Results

Signalment
A total of 16 cats were diagnosed with OM between 2011 and 2016, of which 50% were unilaterally affected and 50% had bilateral OM.
The majority were under 10 years of age (5/ 
Presentation
Half of the cats seen at the referral hospital had shown signs of OE either at the referring veterinary surgery or on presentation at the hospital, of which four had concurrent neurological signs. Figure 1 shows the clinical signs observed in the cats included in the study. A high proportion of cases (11/16 [68.8%]) presented with neurological signs, of which four had OE and neurological signs concurrently.
Diagnostic investigations/tests at the referral hospital
Eleven of 16 cats (68.8%) had a CT scan of their bullae, all of which had evidence of fluid in the bullae and four had bulla wall thickening. Four had MRI scans rather than CT (18.8%), of which 100% showed enhancing material in the bullae (see Figure 2) . Two cats had evidence of otitis interna (one showing enhancement of inner-ear structures on postcontrast images; one having a large and distorted inner ear and enhancement of the semi-circular canals) and one of the two had concurrent meningitis.
Of the four cats that showed evidence of bulla wall thickening, one was treated medically with systemic itraconazole and a topical preparation containing polymyxin B, prednisolone and miconazole (Surolan; Elanco), one underwent a ventral bulla osteotomy (VBO), one was recommended a VBO and one underwent total ear canal ablation (TECA). No recurrence was noted in the three cats that received treatment; no follow-up information was available for the cat that was recommended for VBO surgery.
Five cats had myringotomy procedures. Nine had cytology performed on the aural exudate (n = 4) or material obtained by myringotomy (n = 5). Samples from 9/16 cases (56.3%) were sent for culture and sensitivity testing; a variety of organisms were cultured, including Staphylococcus epidermidis and Staphylococcus aureus (with no significant antimicrobial resistance reported), Escherichia coli, anaerobes, Pasteurella multocida, Mycoplasma species and Pseudomonas aeruginosa ( Table 1 ). The specific organism did not appear to influence the treatment modality or outcome. 
Treatment
Outcomes
One cat had a follow-up CT scan 5 weeks later and one had radiographs after 1 year; both these cats were successfully managed medically, with no signs of bulla effusion seen on the images, which had been present previously. Two cats had continual signs of OE after being medically managed but no signs of OM. Six cats have had no signs of ear disease, either OE or OM, as far as follow-up allows. Of the two cats with concurrent otitis interna, one had continued ataxia and both had head tilt, although these signs were less pronounced than on initial presentation. Follow-up available ranged from 3 months to 2 years. Four cats were euthanased, all for unrelated problems. For two cats, there was no available follow-up information (see Figure 3) .
Discussion
Managing OM in cats with surgical intervention has been well described; 10 to the best of our knowledge there is very little information on medical management. This small, retrospective study shows some evidence that medical management with systemic antibiotics can be successful in treating cats with OM. The nine cats that were managed medically, for which follow-up was available, all appear to have been successfully treated. These Although there were no specific selection criteria in this study, it should be noted that diagnosis of OM in these cats was not solely based on imaging findings; the cats also had to have presented with compatible clinical signs. Previous studies have found that 34 cats out of a cohort of 100 had signs of OM on CT scans of the head yet presented with no signs consistent with ear disease. 14 Studies show that CT and MRI are the most sensitive diagnostic imaging methods of diagnosing OM; 12 it is not, however, known if they are the gold-standard method for monitoring for relapse. Resolution in these cases was based on resolution of clinical signs. Future prospective studies may wish to definitively measure resolution with a combination of advanced imaging techniques.
There is a lack of evidence regarding the use of non-steroidal anti-inflammatory drugs (NSAIDs) in OM cases, whether for analgesia or to reduce inflammation. Although in these cases, it was used mainly for postoperative cases, there were some medically managed cats that also received NSAIDs. Each case was managed by clinicians from different specialities/disciplines so no standardised medical modality was used.
It is stated in some review articles that antimicrobial medication is a valid treatment option in both dogs and cats, whereas others state that topical or systemic antimicrobials are far from ideal in the treatment of OM. 5, 7, 17 These conflicting stances suggest that there is limited good-quality evidence on how to use systemic antimicrobials to treat OM and in which situations they are more likely to succeed, with particularly limited evidence for cats, especially as most of the available evidence is anecdotal or opinion-based, rather than being based on clinical trials. In this study, the duration of antimicrobial therapy did not correlate with outcome, although some cats had shorter durations of treatment than a proposed length of 4-6 weeks. 18 Some authors have stated that systemic antimicrobial therapies may not be able to reach a sufficient concentration in feline and canine bullae, even when given at the maximum oral dose. 5 When planning to use systemic treatment in cats with OM, the results of bacterial culture are vital because this can influence which medication is prescribed. 18 Topical treatment may be effective even if culture indicates a resistant organism, owing to the higher concentrations of drugs that can be applied topically to the ear, in comparison with systemic concentrations. In two cases described, infection with Mycoplasma species was reported. Mycoplasma species infection has also been reported as a cause for OM and Mycoplasma felis is an increasingly recognised cause of disease in cats. 19, 20 This study is limited in that it was retrospective and not prospective; furthermore, the study population was very small. Even so, we hope that it will help to form the basis for further studies evaluating the success or otherwise of managing OM in cats with systemic antimicrobial treatment.
Conclusions
This small cohort shows that some cats with OM can be successfully managed medically. VBO and TECA are invasive surgical procedures that may not necessarily be required in these cases if appropriate medical management is undertaken. 
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